Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Mod GRF 1-29

Sermorelin, Growth Hormone Releasing Hormone (1-29), hGRF(1-29)NH2

Quick Stats
Studies 227
Trials 47
Score 1
1988 pubmed

Role of vasoactive intestinal polypeptide in the internal anal sphincter relaxation of the opossum.

Nurko. S S; Rattan. S S

Key Findings

  • VIP causes a dose‑dependent drop in internal anal sphincter pressure by acting directly on the muscle.
  • A GRF‑derived antagonist (N‑AC‑Tyr1,D‑Phe2‑GRF 1‑29‑NH2) effectively blocks VIP’s inhibitory action.
  • Blocking VIP reduces the sphincter relaxation triggered by the rectoanal reflex by 40‑62%.

Practical Outcomes

  • For most biohackers, this research offers limited direct use. It confirms VIP’s role in bowel muscle control, suggesting that targeting VIP could someday affect constipation or continence, but no actionable dosing or protocol is provided for humans.

Summary

In opossums, the peptide VIP makes the internal anal sphincter relax, and a modified GRF peptide can block this effect. The study shows that VIP directly lowers sphincter pressure and that blocking VIP reduces the natural reflex that relaxes the sphincter by about half.

Abstract

The nature of the inhibitory neurotransmitter responsible for internal anal sphincter (IAS) relaxation in response to rectoanal reflex is not known. The objective of the present investigation was to examine the role of VIP in IAS relaxation in response to the rectoanal reflex in intact opossums with the use of VIP antagonists, [4CI-D-Phe6,Leu17] VIP and (N-AC-Tyr1,D-Phe2)-GRF (1-29)-NH2. Intraluminal pressures from the sphincter were monitored using low-compliance, continuously perfused catheters. VIP and the antagonists were administered close-intraarterially. The responses to VIP, rectoanal reflex, sacral nerve stimulation, and local intramural stimulation were examined before and after the VIP antagonists. The present studies in intact animals show: (a) VIP causes a dose-dependent fall in the IAS pressures by a direct action at the IAS smooth muscle; (b) VIP antagonists selectively and significantly antagonized the inhibitory action of VIP; and (c) VIP antagonists caused significant antagonism of the IAS relaxation caused by rectoanal reflex and the other neural stimuli. The antagonism of the IAS relaxation by the VIP antagonists, depending upon the volume of rectal distension used, ranged from 40% to 62% (P less than 0.05). From these results, we conclude that VIP acts as an inhibitory neurotransmitter for IAS relaxation during the rectoanal reflex.

Study Information

Provider

pubmed

Year

1988

DOI

10.1172/jci113429